Your session is about to expire
← Back to Search
Cerclage for Short Cervix in Twin Pregnancy (TWIN-UIC Trial)
TWIN-UIC Trial Summary
This trial will test if an ultrasound-indicated cerclage reduces the incidence of premature birth in asymptomatic women with twin gestations and a short cervix.
TWIN-UIC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTWIN-UIC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TWIN-UIC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with an infection of the placenta and amniotic fluid.You have a condition called placenta previa.I have twin-twin transfusion syndrome.Your water has broken.You are pregnant with one baby only, not twins or more.I am currently experiencing vaginal bleeding.I experience painful regular contractions.My fetus has a chromosomal abnormality.I do not have any symptoms.You are a twin who shares the same amniotic sac with your sibling.The protective layer around the baby in the womb has come out through the vagina.You have a cervical cerclage in place for a different reason.I am a pregnant woman over 18 years old.You are pregnant with twins who share the same amniotic sac.If you have a pregnancy with more than one fetus, and you have already had a fetal reduction procedure after 14 weeks of pregnancy, you cannot participate in the trial.I'm sorry, but "Labor" is not a complete exclusion criterion. Can you please provide me with more information, so I can help you better?
- Group 1: Cervical cerclage + vaginal progesterone
- Group 2: Vaginal progesterone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment accepting new members at present?
"As per the information provided on clinicaltrials.gov, this trial is currently recruiting participants and was originally posted in June of 2017 with a recent update made to it on April 23rd 2020."
Is this study open to geriatric participants?
"This trial's eligibility guidelines specify that participants must be aged 18 to 60 years old. For individuals below this age range, there are 184 studies available and 74 for those above the cutoff."
Could I qualify as a participant for this medical trial?
"This clinical trial aims to recruit 200 participants who experienced a premature birth and are between 18-60 years old. Notably, the inclusion criteria necessitates that they must have had a diamniotic twin pregnancy, be asymptomatic, and must identify with female gender."
What is the upper limit of participants for this medical experiment?
"Affirmative. Clinicaltrials.gov divulges that this medical trial is presently recruiting, with the first posting dating back to June 22nd 2017 and last updated April 23rd 2020. 200 patients are needed for 3 separate sites."
Share this study with friends
Copy Link
Messenger